Chronic Hepatitis B virus infection program (HebaBiz Biotech)

N/A

Report date: 2025/01/26 17:26:12
NME

Base Information

Drug NameChronic Hepatitis B virus infection program (HebaBiz Biotech)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHebaBiz Biotech
China Registration ClassN/A

Develop Information

Active CompaniesHebaBiz Biotech
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A